መነሻNSIS-B • CPH
add
Novozymes A/S
የቀዳሚ መዝጊያ
kr 475.90
የቀን ክልል
kr 474.70 - kr 480.40
የዓመት ክልል
kr 375.90 - kr 480.40
የገበያው አጠቃላይ ዋጋ
192.02 ቢ DKK
አማካይ መጠን
557.47 ሺ
የዋጋ/ገቢ ምጥጥን
-
የትርፍ ክፍያ
-
ዋና ልውውጥ
CPH
የገበያ ዜና
ፋይናንስ
የገቢ መግለጫ
ገቢ
የተጣራ ገቢ
| (EUR) | ጁን 2024info | ከዓመት ዓመት ለውጥ |
|---|---|---|
ገቢ | 915.85 ሚ | 61.70% |
የሥራ ወጪ | 271.75 ሚ | 52.62% |
የተጣራ ገቢ | 31.95 ሚ | -60.72% |
የተጣራ የትርፍ ክልል | 3.49 | -75.70% |
ገቢ በሼር | — | — |
EBITDA | 150.94 ሚ | -16.50% |
ውጤታማ የግብር ተመን | 29.00% | — |
ቀሪ ሒሳብ ሉሆች
አጠቃላይ ንብረቶች
አጠቃላይ ተጠያቂነቶች
| (EUR) | ጁን 2024info | ከዓመት ዓመት ለውጥ |
|---|---|---|
ጥሬ ገንዘብና የአጭር ጊዜ መዋዕለ ንዋይ | 260.80 ሚ | 85.35% |
አጠቃላይ ንብረቶች | 15.25 ቢ | 302.43% |
አጠቃላይ ተጠያቂነቶች | 4.25 ቢ | 119.23% |
አጠቃላይ እሴት | 11.00 ቢ | — |
የሼሮቹ ብዛት | 277.90 ሚ | — |
የገበያ ዋጋ እና የተገለጸ ዋጋ | 12.02 | — |
የእሴቶች ተመላሽ | 1.83% | — |
የካፒታል ተመላሽ | 2.15% | — |
የገንዘብ ፍሰት
የተጣራ ዝርዝር ገንዘብ በጥሬ ገንዘብ
| (EUR) | ጁን 2024info | ከዓመት ዓመት ለውጥ |
|---|---|---|
የተጣራ ገቢ | 31.95 ሚ | -60.72% |
ከክወናዎች የተገኘ ጥሬ ገንዘብ | 264.05 ሚ | 74.01% |
ገንዘብ ከኢንቨስትመንት | -27.45 ሚ | 70.98% |
ገንዘብ ከፋይናንስ | -186.70 ሚ | -205.10% |
የተጣራ ዝርዝር ገንዘብ በጥሬ ገንዘብ | 55.55 ሚ | 902.56% |
ነፃ የገንዘብ ፍሰት | -17.57 ሚ | 68.87% |
ስለ
Novozymes A/S was a global biotechnology company headquartered in Bagsværd, outside of Copenhagen, Denmark. The company's focus was the research, development and production of industrial enzymes, microorganisms, and biopharmaceutical ingredients. The company merged with Chr. Hansen to form Novonesis in January 2024.
Prior to the merger, the company had operations around the world, including in China, India, Brazil, Argentina, United Kingdom, the United States, and Canada. Class B shares of its stock were listed on the NASDAQ OMX Nordic exchange.
On 12 December 2023, it was announced that Nozozymes and Danish bioscience company Chr. Hansen had obtained regulatory approval for a merger, and on the following day, the name of the combined company was revealed as Novonesis. Wikipedia
ዋና ሥራ አስፈጻሚ
የተመሰረተው
2000
ድህረገፅ
ሠራተኞች
10,452
